UNSPSC 51201620: Smallpox vaccine

This classification denotes a vaccine an acute, highly contagious, often fatal infectious disease caused by an orthopoxvirus characterized by a biphasic febrile course and distinctive progressive skin eruptions. Vaccination has succeeded in eradicating smallpox worldwide.

UNSPSC 51201620 Smallpox vaccine is a Commodity code under which state and local health agencies procure immunization products. The recent solicitation activity under this code does not align with the vaccine name — the Mississippi State Department of Health posted a sole source notice for Yellow Fever Vaccine from Sanofi Pasteur, Inc., rather than smallpox vaccine. State health departments appear to be the primary issuing bodies soliciting under this code, though the single recent opportunity provided offers limited visibility into the breadth of issuing-body participation.

The Mississippi State Department of Health's sole source notice, posted July 13, 2026, with an objection deadline of August 3, 2026 at 10:00 a.m. CST, represents the only recent opportunity visible under this code. The procurement is a sole source notice rather than a competitive RFP, RFQ, IFB, or ITB; the notice does not specify quantity, contract term, estimated value, or pricing. Any party objecting to the sole source designation must submit written objection with supporting documentation to Cynthia Brasher at the Mississippi State Department of Health Purchasing Department demonstrating that alternative sources can supply the vaccine. The mismatch between the code's nominal scope (smallpox vaccine) and the recent opportunity (yellow fever vaccine) suggests the code may see limited activity specific to smallpox procurement, or that state and local issuing bodies are tagging vaccine solicitations across product types to this Commodity code.